Boardroom Alpha
Start trial
← Activism
Activist profile

Velan Capital Investment Management LP

Campaigns
3
Proxy fights
1
Settlements
2
Directors placed
4
Style
Deal-maker

Velan Capital Investment Management LP is one of the U.S. shareholder activists tracked by Boardroom Alpha, with 3 disclosed campaigns since 2022. Recent U.S. targets include Radius Health Inc and Optinose Inc.

Recent activity

Notable Campaigns

YearTickerTargetType
2022RDUS1Radius Health IncProxy fight
2022OPTNOptinose IncCooperation agreement

Full campaign history, dissident slates, per-nominee seat outcomes, and filings timelines inside the platform →

Current positions

Top Holdings

Q ending Jun 30, 2026
TickerCompany% of floatPosition value
EDSAEdesa Biotech Inc
8.58%
$7M
JSPRJasper Therapeutics Inc
8.02%
$1M
TARAProtara Therapeutics Inc
4.81%
$11M
HRTXHeron Therapeutics Inc
4.61%
$4M
STROSutro Biopharma Inc
3.09%
$17M

Full portfolio, position changes by quarter, and overlap with Velan’s likely next targets inside the platform →

Last 12 months

Recent SEC Filings

Portfolio (13F)
Voting (N-PX)

Full filings history with parsed positions, voting records, and dissident-proxy timelines inside the platform →

View all filings on SEC EDGAR ↗
Compare

Other Deal-maker activists

Linked profiles
Elliott Investment Management L.P.37Ancora Advisors, LLC20Engaged Capital20Starboard Value18Trian Fund Management16Legion Partners Asset Management14Barington Capital Group11Engine Capital, L.P.11
Inside Boardroom Alpha

The full Velan Capital Investment Management LP profile

  • →Daily-rescored target prediction from the activist's current 13F overlap
  • →Full detail on every activist board nominee and the election or settlement result
  • →Per-campaign effectiveness scoring across vote outcomes and concessions
  • →Composite influence, vote-strength, and negotiating-leverage scoring
  • →Preferred legal counsel, proxy solicitor, and IR/PR provider history
Request a demoOpen in platform →
Back to research